Cargando…

Trends in economic burden of type 2 diabetes in China: Based on longitudinal claim data

OBJECTIVE: Diabetes is a major health issue in China that has a significant economic burden on society. Understanding the economic impact of diabetes can help policymakers make informed decisions about healthcare spending and priorities. This study aims to estimate the economic burden of patients wi...

Descripción completa

Detalles Bibliográficos
Autores principales: Liu, Xinyi, Zhang, Luying, Chen, Wen
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2023
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10151735/
https://www.ncbi.nlm.nih.gov/pubmed/37143967
http://dx.doi.org/10.3389/fpubh.2023.1062903
_version_ 1785035603556958208
author Liu, Xinyi
Zhang, Luying
Chen, Wen
author_facet Liu, Xinyi
Zhang, Luying
Chen, Wen
author_sort Liu, Xinyi
collection PubMed
description OBJECTIVE: Diabetes is a major health issue in China that has a significant economic burden on society. Understanding the economic impact of diabetes can help policymakers make informed decisions about healthcare spending and priorities. This study aims to estimate the economic burden of patients with diabetes in an urban setting in China and to identify the impact of hospitalization and complications on health care costs for people with diabetes. METHODS: The study was conducted in a sample city located in eastern China. All patients diagnosed with diabetes before January 2015 were identified from the official health management information system, and their social demographics and records of their health care uses and costs were extracted from the claim database from 2014 to 2019. Six groups of complications were identified according to ICD-10 codes. The diabetes-related direct medical cost (DM cost) was described for patients in stratified groups. A multiple linear regression model was applied to identify the effect of hospitalization and complications on the DM cost of diabetic patients. RESULTS: Our research included 44,994 patients with diabetes, the average annual DM costs for diabetic patients increased from 1,292.72 USD in 2014 to 2,092.87 USD in 2019. The costs of diabetes are closely related to hospitalizations and the type and number of complications. The average annual DM cost of patients who were hospitalized was 2.23 times that of those without hospitalization, and it rose as the number of complications increased. Cardiovascular complications and nephropathic complications were the complications that had the greatest impact on patients’ DM costs, increasing by an average of 65 and 54%, respectively. CONCLUSION: The economic burden of diabetes in urban China has increased significantly. Hospitalization and the type and number of complications have significant impacts on the economic burden of patients with diabetes. Efforts should be made to prevent the development of long-term complications in the population with diabetes.
format Online
Article
Text
id pubmed-10151735
institution National Center for Biotechnology Information
language English
publishDate 2023
publisher Frontiers Media S.A.
record_format MEDLINE/PubMed
spelling pubmed-101517352023-05-03 Trends in economic burden of type 2 diabetes in China: Based on longitudinal claim data Liu, Xinyi Zhang, Luying Chen, Wen Front Public Health Public Health OBJECTIVE: Diabetes is a major health issue in China that has a significant economic burden on society. Understanding the economic impact of diabetes can help policymakers make informed decisions about healthcare spending and priorities. This study aims to estimate the economic burden of patients with diabetes in an urban setting in China and to identify the impact of hospitalization and complications on health care costs for people with diabetes. METHODS: The study was conducted in a sample city located in eastern China. All patients diagnosed with diabetes before January 2015 were identified from the official health management information system, and their social demographics and records of their health care uses and costs were extracted from the claim database from 2014 to 2019. Six groups of complications were identified according to ICD-10 codes. The diabetes-related direct medical cost (DM cost) was described for patients in stratified groups. A multiple linear regression model was applied to identify the effect of hospitalization and complications on the DM cost of diabetic patients. RESULTS: Our research included 44,994 patients with diabetes, the average annual DM costs for diabetic patients increased from 1,292.72 USD in 2014 to 2,092.87 USD in 2019. The costs of diabetes are closely related to hospitalizations and the type and number of complications. The average annual DM cost of patients who were hospitalized was 2.23 times that of those without hospitalization, and it rose as the number of complications increased. Cardiovascular complications and nephropathic complications were the complications that had the greatest impact on patients’ DM costs, increasing by an average of 65 and 54%, respectively. CONCLUSION: The economic burden of diabetes in urban China has increased significantly. Hospitalization and the type and number of complications have significant impacts on the economic burden of patients with diabetes. Efforts should be made to prevent the development of long-term complications in the population with diabetes. Frontiers Media S.A. 2023-04-18 /pmc/articles/PMC10151735/ /pubmed/37143967 http://dx.doi.org/10.3389/fpubh.2023.1062903 Text en Copyright © 2023 Liu, Zhang and Chen. https://creativecommons.org/licenses/by/4.0/This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.
spellingShingle Public Health
Liu, Xinyi
Zhang, Luying
Chen, Wen
Trends in economic burden of type 2 diabetes in China: Based on longitudinal claim data
title Trends in economic burden of type 2 diabetes in China: Based on longitudinal claim data
title_full Trends in economic burden of type 2 diabetes in China: Based on longitudinal claim data
title_fullStr Trends in economic burden of type 2 diabetes in China: Based on longitudinal claim data
title_full_unstemmed Trends in economic burden of type 2 diabetes in China: Based on longitudinal claim data
title_short Trends in economic burden of type 2 diabetes in China: Based on longitudinal claim data
title_sort trends in economic burden of type 2 diabetes in china: based on longitudinal claim data
topic Public Health
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10151735/
https://www.ncbi.nlm.nih.gov/pubmed/37143967
http://dx.doi.org/10.3389/fpubh.2023.1062903
work_keys_str_mv AT liuxinyi trendsineconomicburdenoftype2diabetesinchinabasedonlongitudinalclaimdata
AT zhangluying trendsineconomicburdenoftype2diabetesinchinabasedonlongitudinalclaimdata
AT chenwen trendsineconomicburdenoftype2diabetesinchinabasedonlongitudinalclaimdata